We are live on ! Find out more
PIA

Philadelphia International Advisors Portfolio holdings

AUM $239M
1-Year Est. Return 0.61%
This Fund
S&P 500
This Quarter Est. Return
-2.12%
1 Year Est. Return
+0.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$444M
AUM Growth
Cap. Flow
+$459M
Cap. Flow %
103.31%
Top 10 Hldgs %
30.62%
Holding
78
New
78
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$32.8M
2
PBR icon
Petrobras
PBR
+$22.7M
3
SBS icon
Sabesp
SBS
+$13.6M
4
CS
Credit Suisse Group
CS
+$13.1M
5
PKX icon
POSCO
PKX
+$11.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 19.63%
2 Healthcare 12.58%
3 Energy 10.74%
4 Materials 9.18%
5 Industrials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYD icon
51
China Yuchai International
CYD
$1.5B
$100K 0.02%
+5,700
New +$90.7K
BTM
52
DELISTED
OI S.A. SPON ADR REPSTG 3 PFD SHS (BRA)
BTM
$75K 0.02%
+41,900
New +$75K
HNP
53
DELISTED
Huaneng Power Intl, Inc.
HNP
$58K 0.01%
+1,500
New +$63.7K
MTL
54
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$26K 0.01%
+4,500
New +$32.9K
IMOS
55
ChipMOS TECHNOLOGIES
IMOS
$1.88B
$25K 0.01%
+1,180
New +$21.3K
ITUB icon
56
Itaú Unibanco
ITUB
$82.4B
$10K ﹤0.01%
+2,113
New +$11.5K
EC icon
57
Ecopetrol
EC
$36B
$8K ﹤0.01%
+200
New +$9.13K
GFI icon
58
Gold Fields
GFI
$42.8B
$2K ﹤0.01%
+300
New +$1.92K
SBSW icon
59
Sibanye-Stillwater
SBSW
$8.9B
$0 ﹤0.01%
+80
New +$290

Similar funds

Philadelphia International Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Philadelphia International Advisors, which disclosed 78 positions worth $444M. Its ten largest holdings account for 31% of the portfolio.

Its largest position is Teva Pharmaceuticals: 842,396 shares worth $33M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, followed by Healthcare and Energy.

  • Philadelphia International Advisors's largest Q2 2013 buy was Teva Pharmaceuticals: 842,396 shares worth $33M.
  • Philadelphia International Advisors's ten largest holdings make up 31% of its $444M portfolio in Q2 2013.
  • Philadelphia International Advisors disclosed 78 positions in Q2 2013, its first 13F filing on record.

Based on Philadelphia International Advisors's 13F filing for Q2 2013, filed 9 Aug 2013.